SCHEMBL31542071

SCHEMBL31542071

COC(=O)c1ccc(Cc2nc3ccc(Cl)cc3c(=O)n2C2CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.50
TBXA2R P21731 2/20 0.50
PLA2G2A P14555 2/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
IDH1 O75874 9/20 0.45
TSHR P16473 2/20 0.44
PLA2G1B P04054 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44
TPH1 P17752 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31542062 0.87 HDAC6 (0.58) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL31542078 0.86 POLB (0.51) DRD2TBXA2RIDH1TSHRALDH1A1
SCHEMBL31542051 0.72 HDAC6 (0.66) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL31542054 0.72 HDAC6 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL31542082 0.72 POLB (0.63) DRD2TBXA2RTSHRALDH1A1NPSR1
SCHEMBL31542079 0.71 PLA2G2A (0.49) DRD2TBXA2RPLA2G2AHDAC1HDAC2
SCHEMBL31542083 0.69 POLB (0.56) DRD2TBXA2RHDAC8HDAC6TSHR
SCHEMBL31542077 0.68 ALDH1A1 (0.57) DRD2TBXA2RTSHRALDH1A1L3MBTL1
SCHEMBL7254637 0.68 CNR1 (0.58) DRD2TBXA2RALDH1A1MAPTNPSR1
SCHEMBL7411710 0.67 NPC1 (0.60) DRD2TBXA2RALDH1A1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4622964-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION Gilva Therapeutics Co., Ltd. (TW) 2025-10-01 EP disclosed
WO-2025085669-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION GILVA THERAPEUTICS CO., LTD. (CN) 2025-04-24 WO disclosed